TY - JOUR
T1 - Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells
T2 - Role of estrogen receptor-Sp1 interactions
AU - Xie, Wen
AU - Duan, Renqin
AU - Safe, Stephen
PY - 1999
Y1 - 1999
N2 - Adenosine deaminase (ADA) gene expression is induced by 17β-estradiol (E2) in MCF-7 human breast cancer cells, whereas the antiestrogens 4'- hydroxytamoxifen and ICI 182,780 exhibit partial estrogen receptor (ER) agonist/antagonist and antagonist activities, respectively. Previous studies have shown that the -211 to +11 region of the ADA gene promoter contains six GC-rich sites (I-VI) that bind Sp1 protein, and these elements are required for high basal expression. In transient transfection studies with pADA211, which contains the -211 to +11 ADA gene promoter linked to a bacterial chloramphenicol acetyl transferase (CAT) reporter gene, E2 and tamoxifen (but not ICI 182,780) induced CAT activity. Ligand-induced transactivation was observed only in cells cotransfected with expression plasmids for wild- type ER or HE11, which does not contain the DNA-binding domain of the ER. Cotransfection with HE15 and HE19, which contain the DNA-binding domain and activation function-1 (AF-1) and AF-2 of the ER, respectively, did not result in E2-induced activity. Subsequent deletion analysis of the ADA gene promoter showed that Sp1 binding site IV (-79 to -73) was primarily responsible for hormone responsiveness. ER activation of ADA gene expression is another example of an E2-induced gene that is dependent on ER/Sp1 interactions with a site-specific GC-rich motif.
AB - Adenosine deaminase (ADA) gene expression is induced by 17β-estradiol (E2) in MCF-7 human breast cancer cells, whereas the antiestrogens 4'- hydroxytamoxifen and ICI 182,780 exhibit partial estrogen receptor (ER) agonist/antagonist and antagonist activities, respectively. Previous studies have shown that the -211 to +11 region of the ADA gene promoter contains six GC-rich sites (I-VI) that bind Sp1 protein, and these elements are required for high basal expression. In transient transfection studies with pADA211, which contains the -211 to +11 ADA gene promoter linked to a bacterial chloramphenicol acetyl transferase (CAT) reporter gene, E2 and tamoxifen (but not ICI 182,780) induced CAT activity. Ligand-induced transactivation was observed only in cells cotransfected with expression plasmids for wild- type ER or HE11, which does not contain the DNA-binding domain of the ER. Cotransfection with HE15 and HE19, which contain the DNA-binding domain and activation function-1 (AF-1) and AF-2 of the ER, respectively, did not result in E2-induced activity. Subsequent deletion analysis of the ADA gene promoter showed that Sp1 binding site IV (-79 to -73) was primarily responsible for hormone responsiveness. ER activation of ADA gene expression is another example of an E2-induced gene that is dependent on ER/Sp1 interactions with a site-specific GC-rich motif.
UR - http://www.scopus.com/inward/record.url?scp=0032919424&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032919424&partnerID=8YFLogxK
U2 - 10.1210/endo.140.1.6394
DO - 10.1210/endo.140.1.6394
M3 - Article
C2 - 9886828
AN - SCOPUS:0032919424
SN - 0013-7227
VL - 140
SP - 219
EP - 227
JO - Endocrinology
JF - Endocrinology
IS - 1
ER -